中富通(300560) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was ¥285,291,049.38, a decrease of 22.28% compared to ¥367,068,064.30 in the same period last year[4] - Net profit attributable to shareholders was ¥7,670,728.47, down 29.75% from ¥10,919,621.90 year-on-year[4] - The net profit after deducting non-recurring gains and losses was ¥4,106,671.47, a significant decline of 62.12% compared to ¥10,841,486.78 in the previous year[4] - Operating profit decreased to ¥8.54 million from ¥11.68 million, a decline of about 26.5% year-over-year[22] - The basic and diluted earnings per share decreased to ¥0.0334 from ¥0.0475, a decline of approximately 29.0%[23] Cash Flow and Liquidity - The net cash flow from operating activities improved to -¥14,885,232.77, an increase of 49.95% from -¥29,742,257.38 year-on-year[4] - Cash flow from operating activities showed a net outflow of ¥14.89 million, an improvement from a net outflow of ¥29.74 million in the previous period[26] - Cash and cash equivalents at the end of the period increased to ¥290.92 million from ¥235.89 million, marking a rise of approximately 23.3%[26] - The company's cash and cash equivalents decreased from RMB 625,402,544.56 to RMB 546,340,364.10, a reduction of approximately 12.7%[18] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,422,369,114.49, a decrease of 5.80% from ¥2,571,567,067.50 at the end of the previous year[4] - Current assets decreased from RMB 2,019,908,823.67 to RMB 1,874,680,490.06, indicating a reduction of approximately 7.2%[18] - Total liabilities decreased from RMB 1,607,314,467.04 to RMB 1,450,058,692.95, reflecting a decline of about 9.8%[19] - The company's total equity increased from RMB 964,252,600.46 to RMB 972,310,421.54, showing a growth of approximately 0.6%[20] Income and Expenses - Other income for the period was ¥4,912,900, an increase of 212.74% compared to the previous year, primarily due to government subsidies received[10] - The company reported a significant increase in other income to ¥4.91 million from ¥1.57 million, an increase of approximately 212.0% year-over-year[22] - Total operating costs decreased to ¥283.11 million from ¥350.98 million, reflecting a reduction of about 19.4% year-over-year[22] - Research and development expenses remained stable at ¥14.87 million compared to ¥14.82 million in the previous period[22] Investments and Future Outlook - The company has increased its investment in research and development, with capitalized expenditures rising by 76.82% to ¥16,174,000, reflecting ongoing project investments[8] - The company expects a net loss attributable to shareholders for 2024 between RMB 110 million and RMB 165 million, with a loss excluding non-recurring items estimated between RMB 117.72 million and RMB 172.72 million[16] Credit and Receivables - The company reported a significant reduction in credit impairment losses to ¥1,989,200, down 133.38% year-on-year, attributed to improved cash collection and reduced accounts receivable[10] - The company experienced a credit impairment loss of ¥1.99 million, compared to a gain of ¥5.96 million in the previous period[22] - Accounts receivable decreased from RMB 1,101,469,236.35 to RMB 998,521,098.32, a decline of about 9.4%[18]